Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Oil-filled lipid nanoparticles containing 2'-(2-bromohexadecanoyl)-docetaxel for the treatment of breast cancer.

Feng L, Benhabbour SR, Mumper RJ.

Adv Healthc Mater. 2013 Nov;2(11):1451-7. doi: 10.1002/adhm.201300017. Epub 2013 Apr 19.

2.

Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo.

Feng L, Wu H, Ma P, Mumper RJ, Benhabbour SR.

Int J Nanomedicine. 2011;6:2545-56. doi: 10.2147/IJN.S24954. Epub 2011 Oct 21.

3.

Development of a novel orthotopic non-small cell lung cancer model and therapeutic benefit of 2'-(2-bromohexadecanoyl)-docetaxel conjugate nanoparticles.

Peng L, Feng L, Yuan H, Benhabbour SR, Mumper RJ.

Nanomedicine. 2014 Oct;10(7):1497-506. doi: 10.1016/j.nano.2014.03.016. Epub 2014 Apr 4.

4.

2'-(2-bromohexadecanoyl)-paclitaxel conjugate nanoparticles for the treatment of non-small cell lung cancer in an orthotopic xenograft mouse model.

Peng L, Schorzman AN, Ma P, Madden AJ, Zamboni WC, Benhabbour SR, Mumper RJ.

Int J Nanomedicine. 2014 Jul 30;9:3601-10. doi: 10.2147/IJN.S66040. eCollection 2014.

5.

Enhanced Antitumor Efficacy and Reduced Toxicity of Docetaxel Loaded Estradiol Functionalized Stealth Polymeric Nanoparticles.

Jain S, Spandana G, Agrawal AK, Kushwah V, Thanki K.

Mol Pharm. 2015 Nov 2;12(11):3871-84. doi: 10.1021/acs.molpharmaceut.5b00281. Epub 2015 Oct 1.

PMID:
26375023
6.

Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.

Tavassolian F, Kamalinia G, Rouhani H, Amini M, Ostad SN, Khoshayand MR, Atyabi F, Tehrani MR, Dinarvand R.

Int J Pharm. 2014 Jun 5;467(1-2):123-38. doi: 10.1016/j.ijpharm.2014.03.033. Epub 2014 Mar 28.

PMID:
24680951
7.

Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dual modal imaging and chemotherapy of breast cancer.

Abbasi AZ, Prasad P, Cai P, He C, Foltz WD, Amini MA, Gordijo CR, Rauth AM, Wu XY.

J Control Release. 2015 Jul 10;209:186-96. doi: 10.1016/j.jconrel.2015.04.020. Epub 2015 Apr 20.

PMID:
25908171
8.

Dual-Ligand Modified Polymer-Lipid Hybrid Nanoparticles for Docetaxel Targeting Delivery to Her2/neu Overexpressed Human Breast Cancer Cells.

Yang Z, Tang W, Luo X, Zhang X, Zhang C, Li H, Gao D, Luo H, Jiang Q, Liu J.

J Biomed Nanotechnol. 2015 Aug;11(8):1401-17.

PMID:
26295141
9.

Preclinical pharmacokinetic, biodistribution, and anti-cancer efficacy studies of a docetaxel-carboxymethylcellulose nanoparticle in mouse models.

Ernsting MJ, Tang WL, MacCallum NW, Li SD.

Biomaterials. 2012 Feb;33(5):1445-54. doi: 10.1016/j.biomaterials.2011.10.061. Epub 2011 Nov 9.

PMID:
22079003
10.

Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique.

Yu Y, Tan S, Zhao S, Zhuang X, Song Q, Wang Y, Zhou Q, Zhang Z.

Int J Nanomedicine. 2013;8:2641-52. doi: 10.2147/IJN.S48214. Epub 2013 Jul 29.

11.
12.

Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.

Feng SS, Mei L, Anitha P, Gan CW, Zhou W.

Biomaterials. 2009 Jul;30(19):3297-306. doi: 10.1016/j.biomaterials.2009.02.045. Epub 2009 Mar 19.

PMID:
19299012
13.

Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles.

Zhigaltsev IV, Winters G, Srinivasulu M, Crawford J, Wong M, Amankwa L, Waterhouse D, Masin D, Webb M, Harasym N, Heller L, Bally MB, Ciufolini MA, Cullis PR, Maurer N.

J Control Release. 2010 Jun 15;144(3):332-40. doi: 10.1016/j.jconrel.2010.02.029. Epub 2010 Mar 2.

PMID:
20202473
14.

Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting.

Song S, Qi H, Xu J, Guo P, Chen F, Li F, Yang X, Sheng N, Wu Y, Pan W.

Pharm Res. 2014 Nov;31(11):2988-3005. doi: 10.1007/s11095-014-1393-4. Epub 2014 May 20.

PMID:
24842660
15.

Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.

Wang Z, Zeng X, Ma Y, Liu J, Tang X, Gao Y, Liu K, Zhang J, Ming P, Huang L, Mei L.

J Biomed Nanotechnol. 2014 Aug;10(8):1509-19.

PMID:
25016651
16.

Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles.

Esmaeili F, Dinarvand R, Ghahremani MH, Ostad SN, Esmaily H, Atyabi F.

Anticancer Drugs. 2010 Jan;21(1):43-52. doi: 10.1097/CAD.0b013e328331f934.

PMID:
19809300
17.

The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel.

Wang D, Huang J, Wang X, Yu Y, Zhang H, Chen Y, Liu J, Sun Z, Zou H, Sun D, Zhou G, Zhang G, Lu Y, Zhong Y.

Biomaterials. 2013 Oct;34(31):7662-73. doi: 10.1016/j.biomaterials.2013.06.042. Epub 2013 Jul 13.

PMID:
23859657
18.

Ceramide and N,N,N-Trimethylphytosphingosine-Iodide (TMP-I)-Based Lipid Nanoparticles for Cancer Therapy.

Balakrishnan P, Song CK, Jahn A, Cho HJ.

Pharm Res. 2016 Jan;33(1):206-16. doi: 10.1007/s11095-015-1780-5. Epub 2015 Sep 3.

PMID:
26337769
19.

Biocompatibility, efficacy and biodistribution of Gelucire-stabilized nanoparticles engineered for docetaxel delivery.

Wehrung D, Geldenhuys WJ, Bi L, Oyewumi MO.

J Nanosci Nanotechnol. 2012 Mar;12(3):2901-11.

PMID:
22755140
20.

iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability.

Gao F, Zhang J, Fu C, Xie X, Peng F, You J, Tang H, Wang Z, Li P, Chen J.

Int J Nanomedicine. 2017 Jun 1;12:4147-4162. doi: 10.2147/IJN.S134148. eCollection 2017.

Supplemental Content

Support Center